FindTrial
Sign In

Identification and Experimental Validation of Biomarkers for Atopic Dermatitis and Post-Translational Modifications through Integrated Bulk and Single-Cell Transcriptomics Analysis and Machine Learning Techniques

Identification and Experimental Validation of Biomarkers for Atopic Dermatitis and Post-Translational Modifications through Integrated Bulk and Single-Cell Transcriptomics Analysis and Machine Learning Techniques

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122313
Enrollment
Unknown
Registered
2026-04-12
Start date
2026-04-12
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Atopic Dermatitis Observation Group:None

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age range: 18 - 75 years old. Meets the diagnostic criteria for atopic dermatitis in China.

Exclusion criteria

Exclusion criteria: Patients with comorbid other autoimmune diseases, acute infections, pregnancy, or lactation are excluded.

Design outcomes

Primary

MeasureTime frame
Primary Biomarker Expression Profile;—

Countries

China

Contacts

Public ContactTan Rui

Zhujiang Hospital of Southern Medical University

tanrui13@163.com+86 20 62782077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026